Credit Suisse Initiates Coverage on Stericycle (SRCL)
Equities researchers at Credit Suisse initiated coverage on shares of Stericycle (NASDAQ:SRCL) in a research report issued on Monday, TheFlyOnTheWall.com reports. The firm set an “outperform” rating and a $140.00 price target on the stock. Credit Suisse’s price objective indicates a potential upside of 21.72% from the company’s current price.
The analysts wrote, “Barrier to entry in the medical waste business is not just having a disposal network advantage but also high route density similar to the municipal solid waste business,” the report noted. “We believe having captive US market share in a stable business (over 95% of revenues are under long term contracts with automatic renewal clauses) with significant global and domestic secular drivers insulates Stericycle from economic cycles.”
Shares of Stericycle (NASDAQ:SRCL) traded down 0.35% on Monday, hitting $115.02. The stock had a trading volume of 401,912 shares. Stericycle has a 52-week low of $93.19 and a 52-week high of $121.61. The stock’s 50-day moving average is $115.7 and its 200-day moving average is $115.8. The company has a market cap of $9.858 billion and a P/E ratio of 33.26.
Stericycle (NASDAQ:SRCL) last released its earnings data on Wednesday, October 23rd. The company reported $0.96 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.94 by $0.02. The company had revenue of $534.60 million for the quarter, compared to the consensus estimate of $542.38 million. During the same quarter in the prior year, the company posted $0.84 earnings per share. The company’s quarterly revenue was up 11.3% on a year-over-year basis. Analysts expect that Stericycle will post $3.73 EPS for the current fiscal year.
A number of other analysts have also recently weighed in on SRCL. Analysts at RBC Capital initiated coverage on shares of Stericycle in a research note to investors on Friday. They set a “sector perform” rating and a $124.00 price target on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Stericycle in a research note to investors on Tuesday, October 29th. They now have a $122.00 price target on the stock. Finally, analysts at Robert W. Baird raised their price target on shares of Stericycle from $126.00 to $128.00 in a research note to investors on Thursday, October 24th. They now have a “neutral” rating on the stock. Six investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. The company has an average rating of “Buy” and an average price target of $124.68.
Stericycle, Inc, is in the business of managing regulated waste and providing an array of related and complementary services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.